124 related articles for article (PubMed ID: 2738415)
1. Detection of IgG4 antibodies by immunoblotting in patients on vespid venom immunotherapy.
Einarsson R; Inganäs M; Karlsson T; Persson B
J Immunol Methods; 1989 Jun; 120(2):265-9. PubMed ID: 2738415
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of antibodies in patients on immunotherapy with insect venoms by immunoblotting.
Einarsson R
Int Arch Allergy Appl Immunol; 1987; 83(2):217-9. PubMed ID: 3294603
[TBL] [Abstract][Full Text] [Related]
3. Allergens in Hymenoptera venom XV: The immunologic basis of vespid venom cross-reactivity.
Hoffman DR
J Allergy Clin Immunol; 1985 May; 75(5):611-3. PubMed ID: 2580878
[TBL] [Abstract][Full Text] [Related]
4. IgE, IgG, IgG1 and IgG4 patterns in yellow jacket allergic patients during immunotherapy with a venom depot extract.
Jeep S; Meysel U; Kunkel G
Clin Exp Allergy; 1992 Feb; 22(2):297-302. PubMed ID: 1571821
[TBL] [Abstract][Full Text] [Related]
5. Long-term IgG4 determinations in hymenoptera-sensitive treated patients.
Gentlesk MJ; Halpern GM; Mansmann HC
Ann Allergy; 1987 Oct; 59(4):267-72. PubMed ID: 3662129
[TBL] [Abstract][Full Text] [Related]
6. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.
Golden DB; Lawrence ID; Hamilton RH; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):386-93. PubMed ID: 1527321
[TBL] [Abstract][Full Text] [Related]
8. Allergens in Hymenoptera venom. XVI: Studies of the structures and cross-reactivities of vespid venom phospholipases.
Hoffman DR
J Allergy Clin Immunol; 1986 Aug; 78(2):337-43. PubMed ID: 3734285
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A1-based cross-reactivity among venoms of clinically relevant Hymenoptera from Neotropical and temperate regions.
Perez-Riverol A; Fernandes LGR; Musacchio Lasa A; Dos Santos-Pinto JRA; Moitinho Abram D; Izuka Moraes GH; Jabs F; Miehe M; Seismman H; Palma MS; de Lima Zollner R; Spillner E; Brochetto-Braga MR
Mol Immunol; 2018 Jan; 93():87-93. PubMed ID: 29156294
[TBL] [Abstract][Full Text] [Related]
10. Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization.
Monsalve RI; Vega A; Marqués L; Miranda A; Fernández J; Soriano V; Cruz S; Domínguez-Noche C; Sánchez-Morillas L; Armisen-Gil M; Guspí R; Barber D
Allergy; 2012 Apr; 67(4):528-36. PubMed ID: 22229815
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical studies of yellowjacket venom proteins.
King TP; Alagon AC; Kuan J; Sobotka AK; Lichtenstein LM
Mol Immunol; 1983 Mar; 20(3):297-308. PubMed ID: 6865952
[TBL] [Abstract][Full Text] [Related]
12. Comparison of vespid venoms collected by electrostimulation and by venom sac extraction.
Mueller U; Reisman R; Wypych J; Elliott W; Steger R; Walsh S; Arbesman C
J Allergy Clin Immunol; 1981 Oct; 68(4):254-61. PubMed ID: 7288046
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
[TBL] [Abstract][Full Text] [Related]
14. Allergens in Hymenoptera venom XIV: IgE binding activities of venom proteins from three species of vespids.
Hoffman DR
J Allergy Clin Immunol; 1985 May; 75(5):606-10. PubMed ID: 3989146
[TBL] [Abstract][Full Text] [Related]
15. Antigenic cross-reactivity of venom proteins from hornets, wasps, and yellow jackets.
King TP; Joslyn A; Kochoumian L
J Allergy Clin Immunol; 1985 May; 75(5):621-8. PubMed ID: 3989148
[TBL] [Abstract][Full Text] [Related]
16. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
18. Yellow jacket venom allergens, hyaluronidase and phospholipase: sequence similarity and antigenic cross-reactivity with their hornet and wasp homologs and possible implications for clinical allergy.
King TP; Lu G; Gonzalez M; Qian N; Soldatova L
J Allergy Clin Immunol; 1996 Sep; 98(3):588-600. PubMed ID: 8828537
[TBL] [Abstract][Full Text] [Related]
19. Humoral immunological response in patients with venom allergy during specific immunotherapy.
Szymański W; Chyrek-Borowska S
Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
[TBL] [Abstract][Full Text] [Related]
20. Assessment of prolonged venom immunotherapy in children.
Graft DF; Schuberth KC; Kagey-Sobotka A; Kwiterovich KA; Niv Y; Lichtenstein LM; Valentine MD
J Allergy Clin Immunol; 1987 Aug; 80(2):162-9. PubMed ID: 3611537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
